Arcturus Therapeutics Holdings Inc (ARCT)
26.17
-0.81
(-3.00%)
USD |
NASDAQ |
Apr 25, 16:00
26.26
+0.09
(+0.34%)
Pre-Market: 08:53
Arcturus Therapeutics Holdings Cash from Financing (TTM): -24.09M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -24.09M |
September 30, 2023 | -7.662M |
June 30, 2023 | -30.72M |
March 31, 2023 | -30.56M |
December 31, 2022 | -2.859M |
September 30, 2022 | -0.397M |
June 30, 2022 | 1.515M |
March 31, 2022 | 1.34M |
December 31, 2021 | 48.02M |
September 30, 2021 | 210.99M |
June 30, 2021 | 397.52M |
March 31, 2021 | 483.04M |
December 31, 2020 | 436.14M |
September 30, 2020 | 277.98M |
June 30, 2020 | 112.08M |
March 31, 2020 | 42.02M |
December 31, 2019 | 41.91M |
September 30, 2019 | 46.74M |
June 30, 2019 | 25.40M |
March 31, 2019 | 9.91M |
December 31, 2018 | 10.20M |
Date | Value |
---|---|
September 30, 2018 | 1.388M |
June 30, 2018 | 1.86M |
March 31, 2018 | 7.292M |
December 31, 2017 | 6.998M |
September 30, 2017 | 5.936M |
June 30, 2017 | 5.483M |
March 31, 2017 | -0.006M |
December 31, 2016 | 0.00 |
September 30, 2016 | -26.01M |
June 30, 2016 | -26.01M |
March 31, 2016 | -26.00M |
December 31, 2015 | 1.902M |
September 30, 2015 | 27.92M |
June 30, 2015 | 27.92M |
March 31, 2015 | 27.90M |
December 31, 2014 | 0.00 |
September 30, 2014 | 35.36M |
June 30, 2014 | 35.36M |
March 31, 2014 | 57.28M |
December 31, 2013 | 57.40M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-30.72M
Minimum
Jun 2023
483.04M
Maximum
Mar 2021
106.76M
Average
41.91M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
AIM ImmunoTech Inc | 0.485M |
Perspective Therapeutics Inc | 0.785M |
Protalix BioTherapeutics Inc | 24.67M |
Electromed Inc | -0.128M |
Armata Pharmaceuticals Inc | 53.99M |